Expression alternation and function of long non coding RNAs in larynx cancer
محل انتشار: دومین کنگره بین المللی کنسرژنومیکس
سال انتشار: 1403
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 84
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ICGCS02_406
تاریخ نمایه سازی: 17 دی 1403
چکیده مقاله:
The prevalence and mortality rates associated with laryngeal squamous cell carcinoma (LSCC), a subtype of head and neck squamous cell carcinoma (HNSCC), have shown a consistent annual increase. Despite the implementation of intensive treatment modalities, including surgical intervention, radiotherapy, and chemotherapy, the outlook for patients diagnosed with advanced-stage LSCC remains bleak. While the pathogenesis of LSCC is notably intricate, advancements in molecular profiling may provide insights into its underlying causes. Long non-coding RNAs (lncRNAs) are crucial in the regulation of tumors. Current studies indicate that regulating lncRNAs involves transcription, post-transcriptional modifications, and other mechanisms, highlighting their significant role in tumor biology. Methods: According to the essential role of lncRNAs, we summarized some known lncRNAs and their association with signaling pathways in this study. Results: The prognostic signature associated with the PI۳K/Akt signaling pathway demonstrates a strong predictive capability. The overexpression of MNX۱-AS۱, LINC۰۰۳۳۰, and LSAMP-AS۱ has been shown to enhance the proliferation, migration, and invasion of laryngeal cancer cells, thereby activating p-AKT (Ser۴۷۳) and p-PI۳K. Furthermore, DLEU۲ functions as a competing endogenous RNA, modulating PIK۳CD expression by sequestering miR-۳۰c-۵p, which in turn activates the Akt signaling pathway. Consequently, the lncRNA-DLEU۲/miR-۳۰c-۵p/PIK۳CD/Akt axis presents a potential novel prognostic biomarker and therapeutic target for laryngeal squamous cell carcinomas (LSCCs). In a similar vein, RGMB antisense RNA ۱ (RGMB-AS۱) is found to be upregulated in LSCC samples and correlates with unfavorable clinical outcomes in affected patients. Additionally, RGMB-AS۱ influences LSCC cell proliferation and invasion through the miR-۲۲/NLRP۳ axis. Moreover, IGF۲BP۲-AS۱ exhibits high expression levels in laryngeal cancer cell lines, and its knockdown results in reduced migration and proliferation of TU۶۸۶ laryngeal cancer cells by modulating miR-۳۷۵ expression. The overexpression of PART۱ significantly impacts the proliferation, apoptosis, migration, and invasion of LSCC cells in vitro (P < ۰.۰۰۱), suggesting that PART۱ may play a role in inhibiting the onset and progression of LSCC. Conclusion: In conclusion, the identification of key lncRNAs may reveal new therapeutic targets and prognostic markers for patients with LSCC.
کلیدواژه ها:
نویسندگان
Ghazal Shahinpour
Department of biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran
Vahid Keikhah Aria
Department of biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran
Bahar Refaei Najaran Tabasi
Department of biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran
Maliheh Alimardani
Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran